Home NDC 76189-535 Iclusig
Product NDC 76189-535
11-digit product format 761890535
Labeler code 76189
Product ID 76189-535_618b6b2f-ca86-4839-9170-e873e279d592
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ponatinib hydrochloride
Dosage form TABLET, FILM COATED
Route ORAL
Labeler ARIAD Pharmaceuticals, Inc.
Application NDA203469
Marketing category NDA
Marketing start 2012-12-14
Marketing end 2020-07-26
Substance PONATINIB HYDROCHLORIDE
Active strength 15 mg/1
Pharmacologic classes Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 48 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N203469-001 ICLUSIG PONATINIB HYDROCHLORIDE EQ 15MG BASE TABLET / ORAL RLD 2012-12-14 N203469-002 ICLUSIG PONATINIB HYDROCHLORIDE EQ 45MG BASE TABLET / ORAL RLD 2012-12-14 N203469-003 ICLUSIG PONATINIB HYDROCHLORIDE EQ 30MG BASE TABLET / ORAL RLD 2015-04-23 N203469-004 ICLUSIG PONATINIB HYDROCHLORIDE EQ 10MG BASE TABLET / ORAL RLD, RS 2020-12-18
Orange Book patents# Current patent rows page 1 of 1 · 68 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N203469-001 9029533 2026-12-22 U-1283 2015-06-09 N203469-001 9029533 2026-12-22 U-1699 2015-06-09 N203469-001 9029533 2026-12-22 U-1700 2015-06-09 N203469-001 9029533 2026-12-22 U-1701 2015-06-09 N203469-001 9029533 2026-12-22 U-836 2015-06-09 N203469-001 8114874 2027-01-24 Drug substance, Drug product N203469-001 11192895 2033-12-12 U-1700 2022-01-06 N203469-001 11192895 2033-12-12 U-1701 2022-01-06 N203469-001 11192895 2033-12-12 U-1948 2022-01-06 N203469-001 11192897 2033-12-12 U-1700 Drug substance 2022-01-06 N203469-001 11192897 2033-12-12 U-1701 Drug substance 2022-01-06 N203469-001 11192897 2033-12-12 U-1948 Drug substance 2022-01-06 N203469-001 11384086 2033-12-12 U-1700 Drug substance, Drug product 2022-08-03 N203469-001 11384086 2033-12-12 U-1701 Drug substance, Drug product 2022-08-03 N203469-001 11384086 2033-12-12 U-1948 Drug substance, Drug product 2022-08-03 N203469-001 9493470 2033-12-12 U-1700 Drug substance, Drug product 2016-11-29 N203469-001 9493470 2033-12-12 U-1948 Drug substance, Drug product 2016-11-29 N203469-002 9029533 2026-12-22 U-1283 2015-06-09 N203469-002 9029533 2026-12-22 U-1699 2015-06-09 N203469-002 9029533 2026-12-22 U-1700 2015-06-09 N203469-002 9029533 2026-12-22 U-1701 2015-06-09 N203469-002 9029533 2026-12-22 U-836 2015-06-09 N203469-002 8114874 2027-01-24 Drug substance, Drug product N203469-002 11192895 2033-12-12 U-1700 2022-01-06 N203469-002 11192895 2033-12-12 U-1701 2022-01-06 N203469-002 11192895 2033-12-12 U-1948 2022-01-06 N203469-002 11192897 2033-12-12 U-1700 Drug substance 2022-01-06 N203469-002 11192897 2033-12-12 U-1701 Drug substance 2022-01-06 N203469-002 11192897 2033-12-12 U-1948 Drug substance 2022-01-06 N203469-002 11384086 2033-12-12 U-1700 Drug substance, Drug product 2022-08-03 N203469-002 11384086 2033-12-12 U-1701 Drug substance, Drug product 2022-08-03 N203469-002 11384086 2033-12-12 U-1948 Drug substance, Drug product 2022-08-03 N203469-002 9493470 2033-12-12 U-1700 Drug substance, Drug product 2016-11-29 N203469-002 9493470 2033-12-12 U-1948 Drug substance, Drug product 2016-11-29 N203469-003 9029533 2026-12-22 U-1283 2015-06-09 N203469-003 9029533 2026-12-22 U-1699 2015-06-09 N203469-003 9029533 2026-12-22 U-1700 2015-06-09 N203469-003 9029533 2026-12-22 U-1701 2015-06-09 N203469-003 9029533 2026-12-22 U-836 2015-06-09 N203469-003 8114874 2027-01-24 Drug substance, Drug product 2015-06-09 N203469-003 11192895 2033-12-12 U-1700 2022-01-06 N203469-003 11192895 2033-12-12 U-1701 2022-01-06 N203469-003 11192895 2033-12-12 U-1948 2022-01-06 N203469-003 11192897 2033-12-12 U-1700 Drug substance 2022-01-06 N203469-003 11192897 2033-12-12 U-1701 Drug substance 2022-01-06 N203469-003 11192897 2033-12-12 U-1948 Drug substance 2022-01-06 N203469-003 11384086 2033-12-12 U-1700 Drug substance, Drug product 2022-08-03 N203469-003 11384086 2033-12-12 U-1701 Drug substance, Drug product 2022-08-03 N203469-003 11384086 2033-12-12 U-1948 Drug substance, Drug product 2022-08-03 N203469-003 9493470 2033-12-12 U-1700 Drug substance, Drug product 2016-11-29 N203469-003 9493470 2033-12-12 U-1948 Drug substance, Drug product 2016-11-29 N203469-004 9029533 2026-12-22 U-1283 2021-01-14 N203469-004 9029533 2026-12-22 U-1699 2021-01-14 N203469-004 9029533 2026-12-22 U-1700 2021-01-14 N203469-004 9029533 2026-12-22 U-1701 2021-01-14 N203469-004 9029533 2026-12-22 U-836 2021-01-14 N203469-004 8114874 2027-01-24 Drug substance, Drug product 2021-01-14 N203469-004 11192895 2033-12-12 U-1700 2022-01-06 N203469-004 11192895 2033-12-12 U-1701 2022-01-06 N203469-004 11192895 2033-12-12 U-1948 2022-01-06 N203469-004 11192897 2033-12-12 U-1700 Drug substance 2022-01-06 N203469-004 11192897 2033-12-12 U-1701 Drug substance 2022-01-06 N203469-004 11192897 2033-12-12 U-1948 Drug substance 2022-01-06 N203469-004 11384086 2033-12-12 U-1700 Drug substance, Drug product 2022-08-03 N203469-004 11384086 2033-12-12 U-1701 Drug substance, Drug product 2022-08-03 N203469-004 11384086 2033-12-12 U-1948 Drug substance, Drug product 2022-08-03 N203469-004 9493470 2033-12-12 U-1700 Drug substance, Drug product 2021-01-14 N203469-004 9493470 2033-12-12 U-1948 Drug substance, Drug product 2021-01-14
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 8 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 158 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N203469-001 ICLUSIG EQ 15MG BASE TABLET / ORAL RLD 2012-12-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-002 ICLUSIG EQ 45MG BASE TABLET / ORAL RLD 2012-12-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-003 ICLUSIG EQ 30MG BASE TABLET / ORAL RLD 2015-04-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-004 ICLUSIG EQ 10MG BASE TABLET / ORAL RLD, RS 2020-12-18 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203469-001 ICLUSIG EQ 15MG BASE TABLET / ORAL RLD 2012-12-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203469-002 ICLUSIG EQ 45MG BASE TABLET / ORAL RLD, RS 2012-12-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203469-003 ICLUSIG EQ 30MG BASE TABLET / ORAL RLD 2015-04-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N203469-004 ICLUSIG EQ 10MG BASE TABLET / ORAL RLD 2020-12-18 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N203469-001 ICLUSIG EQ 15MG BASE TABLET / ORAL RLD 2012-12-14 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N203469-002 ICLUSIG EQ 45MG BASE TABLET / ORAL RLD, RS 2012-12-14 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N203469-003 ICLUSIG EQ 30MG BASE TABLET / ORAL RLD 2015-04-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N203469-004 ICLUSIG EQ 10MG BASE TABLET / ORAL RLD 2020-12-18 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N203469-001 ICLUSIG EQ 15MG BASE TABLET / ORAL RLD 2012-12-14 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N203469-002 ICLUSIG EQ 45MG BASE TABLET / ORAL RLD, RS 2012-12-14 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N203469-003 ICLUSIG EQ 30MG BASE TABLET / ORAL RLD 2015-04-23 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N203469-004 ICLUSIG EQ 10MG BASE TABLET / ORAL RLD 2020-12-18 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N203469-001 ICLUSIG EQ 15MG BASE TABLET / ORAL RLD 2012-12-14 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N203469-002 ICLUSIG EQ 45MG BASE TABLET / ORAL RLD, RS 2012-12-14 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N203469-003 ICLUSIG EQ 30MG BASE TABLET / ORAL RLD 2015-04-23 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N203469-004 ICLUSIG EQ 10MG BASE TABLET / ORAL RLD 2020-12-18 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N203469-001 ICLUSIG EQ 15MG BASE TABLET / ORAL RLD 2012-12-14 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N203469-002 ICLUSIG EQ 45MG BASE TABLET / ORAL RLD, RS 2012-12-14 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N203469-003 ICLUSIG EQ 30MG BASE TABLET / ORAL RLD 2015-04-23 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N203469-004 ICLUSIG EQ 10MG BASE TABLET / ORAL RLD 2020-12-18 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N203469-001 ICLUSIG EQ 15MG BASE TABLET / ORAL RLD 2012-12-14 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N203469-002 ICLUSIG EQ 45MG BASE TABLET / ORAL RLD, RS 2012-12-14 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N203469-003 ICLUSIG EQ 30MG BASE TABLET / ORAL RLD 2015-04-23 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N203469-004 ICLUSIG EQ 10MG BASE TABLET / ORAL RLD 2020-12-18 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N203469-001 ICLUSIG EQ 15MG BASE TABLET / ORAL RLD 2012-12-14 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N203469-002 ICLUSIG EQ 45MG BASE TABLET / ORAL RLD, RS 2012-12-14 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N203469-003 ICLUSIG EQ 30MG BASE TABLET / ORAL RLD 2015-04-23 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N203469-004 ICLUSIG EQ 10MG BASE TABLET / ORAL RLD 2020-12-18 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N203469-001 ICLUSIG EQ 15MG BASE TABLET / ORAL RLD 2012-12-14 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N203469-002 ICLUSIG EQ 45MG BASE TABLET / ORAL RLD, RS 2012-12-14 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N203469-003 ICLUSIG EQ 30MG BASE TABLET / ORAL RLD 2015-04-23 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N203469-004 ICLUSIG EQ 10MG BASE TABLET / ORAL RLD 2020-12-18 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N203469-001 ICLUSIG EQ 15MG BASE TABLET / ORAL RLD 2012-12-14 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N203469-002 ICLUSIG EQ 45MG BASE TABLET / ORAL RLD, RS 2012-12-14 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N203469-003 ICLUSIG EQ 30MG BASE TABLET / ORAL RLD 2015-04-23 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N203469-004 ICLUSIG EQ 10MG BASE TABLET / ORAL RLD 2020-12-18 d06236e962d9…
Observed Orange Book patent history# Patent history page 1 of 59 · 2,356 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N203469-001 9029533 2026-12-22 U-1700 2015-06-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-001 9029533 2026-12-22 U-836 2015-06-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-001 9029533 2026-12-22 U-1701 2015-06-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-001 9029533 2026-12-22 U-1699 2015-06-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-001 9029533 2026-12-22 U-1283 2015-06-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-001 8114874 2027-01-24 Drug substance, Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-001 11192895 2033-12-12 U-1700 2022-01-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-001 11192895 2033-12-12 U-1701 2022-01-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-001 11192895 2033-12-12 U-1948 2022-01-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-001 11192897 2033-12-12 U-1700 Drug substance 2022-01-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-001 11192897 2033-12-12 U-1701 Drug substance 2022-01-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-001 11192897 2033-12-12 U-1948 Drug substance 2022-01-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-001 11384086 2033-12-12 U-1700 Drug substance, Drug product 2022-08-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-001 11384086 2033-12-12 U-1948 Drug substance, Drug product 2022-08-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-001 11384086 2033-12-12 U-1701 Drug substance, Drug product 2022-08-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-001 9493470 2033-12-12 U-1700 Drug substance, Drug product 2016-11-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-001 9493470 2033-12-12 U-1948 Drug substance, Drug product 2016-11-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-002 9029533 2026-12-22 U-1283 2015-06-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-002 9029533 2026-12-22 U-1700 2015-06-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-002 9029533 2026-12-22 U-1701 2015-06-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-002 9029533 2026-12-22 U-836 2015-06-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-002 9029533 2026-12-22 U-1699 2015-06-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-002 8114874 2027-01-24 Drug substance, Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-002 11192895 2033-12-12 U-1700 2022-01-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-002 11192895 2033-12-12 U-1701 2022-01-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-002 11192895 2033-12-12 U-1948 2022-01-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-002 11192897 2033-12-12 U-1700 Drug substance 2022-01-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-002 11192897 2033-12-12 U-1701 Drug substance 2022-01-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-002 11192897 2033-12-12 U-1948 Drug substance 2022-01-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-002 11384086 2033-12-12 U-1948 Drug substance, Drug product 2022-08-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-002 11384086 2033-12-12 U-1701 Drug substance, Drug product 2022-08-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-002 11384086 2033-12-12 U-1700 Drug substance, Drug product 2022-08-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-002 9493470 2033-12-12 U-1948 Drug substance, Drug product 2016-11-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-002 9493470 2033-12-12 U-1700 Drug substance, Drug product 2016-11-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-003 9029533 2026-12-22 U-1701 2015-06-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-003 9029533 2026-12-22 U-836 2015-06-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-003 9029533 2026-12-22 U-1283 2015-06-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-003 9029533 2026-12-22 U-1700 2015-06-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-003 9029533 2026-12-22 U-1699 2015-06-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N203469-003 8114874 2027-01-24 Drug substance, Drug product 2015-06-09 011fe1cb6892…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 6 · 204 observed states.
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ponatinib hydrochloride ACTIVE INGREDIENT 96R6PU3D8J ICLUSIG (PONATINIB HYDROCHLORIDE) TABLET, FILM COATED [ARIAD PHARMACEUTICALS, INC.] 7 ponatinib ACTIVE MOIETY 4340891KFS ICLUSIG (PONATINIB HYDROCHLORIDE) TABLET, FILM COATED [ARIAD PHARMACEUTICALS, INC.] 7 cellulose, microcrystalline INACTIVE INGREDIENT OP1R32D61U ICLUSIG (PONATINIB HYDROCHLORIDE) TABLET, FILM COATED [ARIAD PHARMACEUTICALS, INC.] 7 lactose monohydrate INACTIVE INGREDIENT EWQ57Q8I5X ICLUSIG (PONATINIB HYDROCHLORIDE) TABLET, FILM COATED [ARIAD PHARMACEUTICALS, INC.] 7 magnesium stearate INACTIVE INGREDIENT 70097M6I30 ICLUSIG (PONATINIB HYDROCHLORIDE) TABLET, FILM COATED [ARIAD PHARMACEUTICALS, INC.] 7 silicon dioxide INACTIVE INGREDIENT ETJ7Z6XBU4 ICLUSIG (PONATINIB HYDROCHLORIDE) TABLET, FILM COATED [ARIAD PHARMACEUTICALS, INC.] 7 sodium starch glycolate type B potato INACTIVE INGREDIENT 27NA468985 ICLUSIG (PONATINIB HYDROCHLORIDE) TABLET, FILM COATED [ARIAD PHARMACEUTICALS, INC.] 7
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Iclusig PONATINIB HYDROCHLORIDE Takeda Pharmaceuticals America, Inc. 16d804b6-4957-43ee-b18c-3b36ec37c5ac 2026-04-29 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 203469 application number: NDA203469